Paats Joosep, Adoberg Annika, Arund Jürgen, Dhondt Annemieke, Fernström Anders, Fridolin Ivo, Glorieux Griet, Gonzalez-Parra Emilio, Holmar Jana, Leis Liisi, Luman Merike, Perez-Gomez Vanessa Maria, Pilt Kristjan, Sanchez-Ospina Didier, Segelmark Mårten, Uhlin Fredrik, Ortiz Alberto
Department of Health Technologies, Tallinn University of Technology, Tallinn, Estonia.
Centre of Nephrology, North Estonia Medical Centre, Tallinn, Estonia.
Clin Kidney J. 2022 Dec 20;16(4):735-744. doi: 10.1093/ckj/sfac273. eCollection 2023 Apr.
Kt/V is the most used marker to estimate dialysis adequacy; however, it does not reflect the removal of many other uraemic toxins, and a new approach is needed. We have assessed the feasibility of estimating intradialytic serum time-averaged concentration (TAC) of various uraemic toxins from their spent dialysate concentrations that can be estimated non-invasively online with optical methods.
Serum and spent dialysate levels and total removed solute (TRS) of urea, uric acid (UA), indoxyl sulphate (IS) and β2-microglobulin (β2M) were evaluated with laboratory methods during 312 haemodialysis sessions in 78 patients with four different dialysis treatment settings. TAC was calculated from serum concentrations and evaluated from TRS and logarithmic mean concentrations of spent dialysate (MD).
Mean (± standard deviation) intradialytic serum TAC values of urea, UA, β2M and IS were 10.4 ± 3.8 mmol/L, 191.6 ± 48.1 µmol/L, 13.3 ± 4.3 mg/L and 82.9 ± 43.3 µmol/L, respectively. These serum TAC values were similar and highly correlated with those estimated from TRS [10.5 ± 3.6 mmol/L ( = 0.92), 191.5 ± 42.8 µmol/L ( = 0.79), 13.0 ± 3.2 mg/L ( = 0.59) and 82.7 ± 40.0 µmol/L ( = 0.85)] and from MD [10.7 ± 3.7 mmol/L ( = 0.92), 191.6 ± 43.8 µmol/L ( = 0.80), 12.9 ± 3.2 mg/L ( = 0.63) and 82.2 ± 38.6 µmol/L ( = 0.84)], respectively.
Intradialytic serum TAC of different uraemic toxins can be estimated non-invasively from their concentration in spent dialysate. This sets the stage for TAC estimation from online optical monitoring of spent dialysate concentrations of diverse solutes and for further optimization of estimation models for each uraemic toxin.
Kt/V是评估透析充分性最常用的指标;然而,它并不能反映许多其他尿毒症毒素的清除情况,因此需要一种新的方法。我们评估了根据透析废液中各种尿毒症毒素的浓度无创在线光学估计法来估算透析期间血清时间平均浓度(TAC)的可行性。
采用实验室方法对78例患者在4种不同透析治疗设置下的312次血液透析治疗过程中的血清和透析废液水平以及尿素、尿酸(UA)、硫酸吲哚酚(IS)和β2-微球蛋白(β2M)的总清除溶质(TRS)进行了评估。根据血清浓度计算TAC,并从TRS和透析废液的对数平均浓度(MD)进行评估。
尿素、UA、β2M和IS的透析期间血清TAC平均值(±标准差)分别为10.4±3.8 mmol/L、191.6±48.1 μmol/L、13.3±4.3 mg/L和82.9±43.3 μmol/L。这些血清TAC值相似,且与根据TRS估算的值[10.5±3.6 mmol/L(r = 0.92)、191.5±42.8 μmol/L(r = 0.79)、13.0±3.2 mg/L(r = 0.59)和82.7±40.0 μmol/L(r = 0.85)]以及根据MD估算的值[10.7±3.7 mmol/L(r = 0.92)、191.6±43.8 μmol/L(r = 0.80)、12.9±3.2 mg/L(r = 0.63)和82.2±38.6 μmol/L(r = 0.84)]高度相关。
不同尿毒症毒素的透析期间血清TAC可根据透析废液中的浓度进行无创估算。这为通过在线光学监测透析废液中多种溶质的浓度来估算TAC以及进一步优化每种尿毒症毒素的估算模型奠定了基础。